A Multi-Omics Approach Reveals Novel Regulators of Plasma Factor V Levels: highlight on CLEC4M as a Clearance Receptor
Blood Journal, 2025
Munsch G., Mohapatra A., van Hylckama Vlieg A., Kleber M., Martinez-Perez A., Le N., Hindberg K., Dusart P., Germain M., Thibord F., Deleuze J., Delgado G., Goumidi L., Suchon P., Saut N., Souto J., Butler L., Soria J., Hansen J., März W., Rosendaal F., Castoldi E., Peiretti F., Sabater-Lleal M., Tregouet D., Morange P.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Hematology | Cross-platform Validation | Plasma |  Olink Explore 3072/384 |
Abstract
Coagulation factor V (FV) is a key protein in maintaining the hemostatic balance, with abnormal plasma levels associated with both thrombotic and hemorrhagic conditions. We propose a comprehensive bioinformatic analysis integrating large scale proteogenomics and transcriptomic data from original and public datasets. We identify a biological fingerprint of 26 new proteins and loci involved in the regulation of plasma FV levels. Furthermore, the mRNA expression levels of 10 of these components show strong correlation in liver. In addition, we provide experimental evidence for the involvement of one of the newly identified players (CLEC4M) in the clearance of FV. This work opens new avenues for a better understanding of the physiological processes involved in thrombotic and bleeding disorders.